JP2024509095A5 - - Google Patents
Info
- Publication number
- JP2024509095A5 JP2024509095A5 JP2023551690A JP2023551690A JP2024509095A5 JP 2024509095 A5 JP2024509095 A5 JP 2024509095A5 JP 2023551690 A JP2023551690 A JP 2023551690A JP 2023551690 A JP2023551690 A JP 2023551690A JP 2024509095 A5 JP2024509095 A5 JP 2024509095A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- section
- items
- item
- mosm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163153920P | 2021-02-25 | 2021-02-25 | |
| US202163153905P | 2021-02-25 | 2021-02-25 | |
| US63/153,905 | 2021-02-25 | ||
| US63/153,920 | 2021-02-25 | ||
| US202163165042P | 2021-03-23 | 2021-03-23 | |
| US202163165021P | 2021-03-23 | 2021-03-23 | |
| US63/165,021 | 2021-03-23 | ||
| US63/165,042 | 2021-03-23 | ||
| US202163167606P | 2021-03-29 | 2021-03-29 | |
| US202163167608P | 2021-03-29 | 2021-03-29 | |
| US63/167,608 | 2021-03-29 | ||
| US63/167,606 | 2021-03-29 | ||
| US202163181224P | 2021-04-28 | 2021-04-28 | |
| US63/181,224 | 2021-04-28 | ||
| US202163273141P | 2021-10-28 | 2021-10-28 | |
| US63/273,141 | 2021-10-28 | ||
| PCT/US2022/017774 WO2022182915A1 (en) | 2021-02-25 | 2022-02-24 | Methods for culturing cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509095A JP2024509095A (ja) | 2024-02-29 |
| JP2024509095A5 true JP2024509095A5 (https=) | 2025-03-06 |
Family
ID=80738784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551690A Withdrawn JP2024509095A (ja) | 2021-02-25 | 2022-02-24 | 細胞の培養方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240228957A9 (https=) |
| EP (1) | EP4298208A1 (https=) |
| JP (1) | JP2024509095A (https=) |
| KR (1) | KR20230150833A (https=) |
| AU (1) | AU2022226660A1 (https=) |
| CA (1) | CA3172318A1 (https=) |
| IL (1) | IL304349A (https=) |
| TW (1) | TW202302842A (https=) |
| WO (1) | WO2022182915A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021189008A1 (en) | 2020-03-20 | 2021-09-23 | Lyell Immunopharma, Inc. | Novel recombinant cell surface markers |
| CA3158133A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
| IL312204A (en) * | 2021-10-28 | 2024-06-01 | Lyell Immunopharma Inc | Methods for culturing cells expressing ror1-binding protein |
| NL2035656B1 (en) * | 2023-08-23 | 2025-03-06 | Cimaas B V | Method of preparing a solution of mitotically suppressed cells |
| CN118165933B (zh) * | 2024-05-14 | 2024-07-16 | 成都美杰赛尔生物科技有限公司 | 组合物、提高cd39-cd69-t细胞比例的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86278A (en) | 1988-05-04 | 2003-06-24 | Yeda Res & Dev | Endowing cells with antibody specificity using chimeric t cell receptor |
| WO2015157636A1 (en) | 2014-04-10 | 2015-10-15 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy |
| GB2592821B (en) | 2015-07-31 | 2022-01-12 | Univ Minnesota | Modified cells and methods of therapy |
| MX2018004721A (es) | 2015-10-23 | 2018-07-06 | Eureka Therapeutics Inc | Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas. |
| TWI788307B (zh) | 2016-10-31 | 2023-01-01 | 美商艾歐凡斯生物治療公司 | 用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞 |
| MX2019007963A (es) | 2017-01-06 | 2019-10-21 | Iovance Biotherapeutics Inc | Expansion de linfocitos infiltrantes de tumor (til) con agonistas de la superfamilia de recptor de factor de necrosis tumoral (tnfrsf) y combinaciones terapeuticas de til- y agonistas de tnfrsf. |
| JOP20190224A1 (ar) | 2017-03-29 | 2019-09-26 | Iovance Biotherapeutics Inc | عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي |
| JP7538601B2 (ja) | 2017-04-26 | 2024-08-22 | ユーリカ セラピューティックス， インコーポレイテッド | キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用 |
| CA3090795A1 (en) | 2018-02-13 | 2019-08-22 | Iovance Biotherapeutics, Inc. | Expansion of tumor infiltrating lymphocytes (tils) with adenosine a2a receptor antagonists and therapeutic combinations of tils and adenosine a2a receptor antagonists |
| WO2019217753A1 (en) | 2018-05-10 | 2019-11-14 | Iovance Biotherapeutics, Inc. | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| US20210386788A1 (en) | 2018-10-24 | 2021-12-16 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
| WO2020096927A1 (en) | 2018-11-05 | 2020-05-14 | Iovance Biotherapeutics, Inc. | Expansion of tils utilizing akt pathway inhibitors |
| BR112022011795A2 (pt) | 2019-12-20 | 2022-08-30 | Instil Bio Uk Ltd | Métodos para preparar e isolar uma população terapêutica de linfócitos e para tratar câncer em um indivíduo, população terapêutica de linfócitos, bolsa criopreservada, recipiente flexível, e, sistema para extração de linfócitos |
| CN111440773B (zh) * | 2020-04-07 | 2023-03-14 | 上海交通大学 | 一种t细胞体外嵌合抗原受体改造及扩增的优化培养方法 |
-
2022
- 2022-02-24 EP EP22710248.0A patent/EP4298208A1/en active Pending
- 2022-02-24 US US18/548,006 patent/US20240228957A9/en active Pending
- 2022-02-24 CA CA3172318A patent/CA3172318A1/en active Pending
- 2022-02-24 AU AU2022226660A patent/AU2022226660A1/en active Pending
- 2022-02-24 WO PCT/US2022/017774 patent/WO2022182915A1/en not_active Ceased
- 2022-02-24 KR KR1020237032289A patent/KR20230150833A/ko active Pending
- 2022-02-24 JP JP2023551690A patent/JP2024509095A/ja not_active Withdrawn
- 2022-02-25 TW TW111107194A patent/TW202302842A/zh unknown
-
2023
- 2023-07-10 IL IL304349A patent/IL304349A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509095A5 (https=) | ||
| JP2023524047A5 (https=) | ||
| JP7566817B2 (ja) | 固形腫瘍を標的とする二重特異性ｃａｒ ｔ細胞 | |
| US11690872B2 (en) | Methods for expanding and activating γδ T cells for the treatment of cancer and related malignancies | |
| JP2021522798A5 (https=) | ||
| JP2021521818A (ja) | 有効な免疫療法のための抗原−サイトカイン複合体に用いた免疫エフェクター細胞及び分子アダプター | |
| ES2816450T3 (es) | Uso de CAR basados en ICOS para mejorar la actividad antitumoral y la persistencia del CAR | |
| ES2988584T3 (es) | Subconjunto de células NKT para persistencia y actividad terapéutica in vivo y propagación del mismo | |
| JP2020141677A (ja) | 改変ナチュラルキラー細胞及びその使用 | |
| JP2018522567A5 (https=) | ||
| JP2022513131A (ja) | 複数の免疫細胞タイプの同時増殖のための方法、関連する組成物および癌免疫療法におけるそれらの使用 | |
| JP2021501604A5 (https=) | ||
| CN115768879A (zh) | 用于培养细胞的方法 | |
| KR20190039597A (ko) | 세포 치료요법을 위한 항상성 활성 사이토킨 수용체 | |
| JP2017536812A (ja) | バイパータイト型およびトリパータイト型のシグナル伝達免疫細胞 | |
| CN105452287A (zh) | 免疫抑制性TGF-β信号转换器 | |
| Fantini et al. | Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy | |
| JP2024520676A5 (https=) | ||
| JP2023521037A5 (https=) | ||
| KR20230150833A (ko) | 세포 배양 방법 | |
| JP2021530224A (ja) | 臍帯血からのｃｉｋ ｎｋｔ細胞の作製方法 | |
| WO2016020434A1 (en) | Method for expanding immune cells | |
| Lv et al. | γδT cells, a key subset of T cell for cancer immunotherapy | |
| Wang et al. | Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy | |
| Lisiero et al. | Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12–primed CD8+ T cells in a melanoma model |